This review focuses upon interactions and potential therapeutic targets in the 'vicious
cycle'between hypoxia and neoangiogenesis following treatment of hepatocellular …

Background: The main aim of this study was to investigate comprehensively the clinical
effect of hepatic arterial infusion chemotherapy (HAIC) on patients suffering from …

Background Hyperprogressive disease (HPD) is a new progressive pattern in patients with
advanced hepatocellular carcinoma (HCC) treated with programmed cell death 1 (PD-1) …

Background Using data collected in the prospective observational study CIRSE Registry for
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …

Purpose Patients with hepatocellular carcinoma and portal vein tumor thrombus have a poor
prognosis and limited therapeutic options. We sought to compare survival, tolerability, and …

Interventional radiology has experienced an exponential growth in the last years. Nowadays
it is possible to treat painful benign lesions or metastases with optimal results in terms of …

Immune checkpoint inhibitors (ICIs) have emerged as effective therapeutics for multiple
cancers. Nevertheless, as immunotherapeutic approaches are being extensively utilized …

Interventional oncology (IO) procedures have become extremely popular in interventional
radiology (IR) and play an essential role in the diagnosis, treatment, and supportive care of …

Purpose Prior to 90Y radioembolization, a pretreatment procedure is performed, in which
99mTc‐macroaggerated albumin (99mTc‐MAA) is administered to estimate the amount of …

Objectives Yttrium-90 transarterial radioembolization (TARE) is a safe, effective modality of
locoregional therapy for intermediate and advanced-stage hepatocellular carcinoma (HCC) …